Hyperpolarized (HP) 13C MRI is a new technique that can assess the metabolic pathways in a variety of tumors. In this study, we show the ability of a gadolinium-based contrast agent (gadoxetate) to selectively suppress the HP metabolic signal arising from normal hepatocytes by altering the relaxation rates of metabolites 13C pyruvate and 13C lactate in order to evaluate the metabolic profile of tumors within the liver.
This abstract and the presentation materials are available to members only; a login is required.